BioTiChe announces its formation as a spin-out from Autifony Therapeutics

BioTiChe today announced its formation as a biotechnology company focused on the discovery and development of innovative small-molecule therapeutics. Built on the principle “From Target to Clinical Candidate, Together,” BioTiChe operates as an integrated chemistry and biology discovery company creating small molecules for central nervous system (CNS) and lysosomal diseases. BioTiChe was established as a […]